RESUMEN
Asymmetry assessment is an important step towards melanoma detection. This paper compares some of the color asymmetry features proposed in the literature which have been used to automatically detect melanoma from color images. A total of nine features were evaluated based on their accuracy in predicting lesion asymmetry on a dataset of 277 images. In addition, the accuracies of these features in differentiating melanoma from benign lesions were compared. Results show that simple features based on the brightness difference between the two halves of the lesion performed the best in predicting asymmetry and subsequently melanoma.Clinical relevance- The proposed work will assist researchers in choosing better performing color asymmetry features thereby improving the accuracy of automatic melanoma detection. The resulting system will reduce the workload of clinicians by screening out obviously benign cases and referring only the suspicious cases to them.
Asunto(s)
Melanoma , Neoplasias Cutáneas , Algoritmos , Dermoscopía , Humanos , Interpretación de Imagen Asistida por Computador , Melanoma/diagnóstico , Neoplasias Cutáneas/diagnósticoRESUMEN
BACKGROUND: Alopecia areata (AA) is usually a benign cause of patchy hair loss that often resolves within a few weeks to months. Most treatment modalities are ineffective in the treatment of severe AA. The use of paint psoralen and ultraviolet-A (PUVA) in the treatment of patients with severe forms of AA has been reported in the literature. AIMS AND OBJECTIVE: The aim of this study was to evaluate the effectiveness of paint PUVA therapy in the treatment of AA in Singapore. MATERIALS AND METHODS: We performed a 10-year retrospective analysis of patients who underwent paint PUVA for AA. We evaluated patient demographics and treatment outcomes in the form of percentage change in baseline severity of alopecia tool score and final amount of hair regrowth and relapse rate. RESULTS: Ten patients were included in this study. With paint PUVA therapy, significant hair regrowth was seen in six patients. Paint PUVA therapy in our study showed minimal side effects. CONCLUSION: PUVA gives fair response in AA in a reasonable time as per our center's experience in Singapore.
Asunto(s)
Nevo Azul/diagnóstico , Nevo de Células Epitelioides y Fusiformes/diagnóstico , Nevo Intradérmico/diagnóstico , Neoplasias Cutáneas/diagnóstico , Niño , Femenino , Humanos , Nevo Azul/patología , Nevo de Células Epitelioides y Fusiformes/patología , Nevo Intradérmico/patología , Neoplasias Cutáneas/patologíaRESUMEN
We report an unusual case of a 49-year-old woman who presented with persistent papulonodules over bilateral fingers and inframammary region in conjunction with features of connective tissue disease including symmetrical polyarthritis and Raynaud phenomenon. Skin biopsy showed an upper-to-mid dermal proliferation of bland spindled cells with thickened collagen bundles and occasional multinucleated giant cells. Dermal blood vessels were only marginally increased. On immunohistochemistry, both the spindled cells and multinucleated giant cells stained negatively for smooth muscle actin. Some of the spindled cells stained positively with CD68 and CD163, whereas the multinucleated giant cells stained negatively for both stains. Elastic fibers were absent on elastic Van Gieson. The clinical and histopathologic features raise a diagnostic dilemma between fibroblastic rheumatism and multinucleate cell angiohistiocytoma. The patient responded well to cyclosporine and methotrexate therapy, with gradual improvement of the finger nodules.
Asunto(s)
Fibroblastos/patología , Células Gigantes/patología , Enfermedades Reumáticas/diagnóstico , Enfermedades de la Piel/diagnóstico , Neoplasias Cutáneas/diagnóstico , Antirreumáticos/uso terapéutico , Ciclosporina/uso terapéutico , Diagnóstico Diferencial , Femenino , Hemangioma/diagnóstico , Hemangioma/tratamiento farmacológico , Hemangioma/patología , Histiocitoma/diagnóstico , Histiocitoma/tratamiento farmacológico , Histiocitoma/patología , Humanos , Inmunosupresores/uso terapéutico , Metotrexato/uso terapéutico , Persona de Mediana Edad , Enfermedades Reumáticas/tratamiento farmacológico , Enfermedades Reumáticas/patología , Enfermedades de la Piel/tratamiento farmacológico , Enfermedades de la Piel/patología , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/patologíaAsunto(s)
Oído/patología , Púrpura/diagnóstico , Femenino , Humanos , Persona de Mediana Edad , Púrpura/complicacionesRESUMEN
The patient's immune status offered a clue to the diagnosis.
Asunto(s)
Exantema/virología , Herpes Zóster/diagnóstico , Exantema/patología , Femenino , Pie , Humanos , Persona de Mediana EdadRESUMEN
Objective: We compared the irritancy potential of sodium lauryl sulfate (SLS)-free aqueous cream to SLS-containing aqueous cream and other moisturizers. Design: This was a double-blind, intraindividual occlusive study. SLS-containing aqueous cream; SLS-free aqueous cream; white soft paraffin; urea cream; Physiogel® (Stiefel Laboratories, Brentford, United Kingdom); QV cream (Ego Pharmaceuticals Pty. Ltd., Braeside, Australia); Cetaphil RestoraDerm® (Galderma Laboratories, Fort Worth, Texas); Ceradan® (Hyphens Pharma International Ltd., Singapore); normal saline; and SLS 1% aqueous were applied with Finn chamber occlusion to different sites on each participant's back for 72 hours. Skin assessments were carried out on Day 0 preapplication and Day 3 and Day 7 postapplication. Participants: Twelve healthy adult volunteers were included in this study. Measurements: Study subjects were clinically evaluated by an experienced dermatologist using a four-point severity scale to assess the severity of erythema, dryness, desquamation, stinging or burning, and pruritus. Corneometer® and transepidermal water loss (TEWL) readings were taken to assess skin hydration and skin barrier integrity, respectively. All measurements were performed on Days 0, 3, and 7. Results: Application of the SLS-free aqueous cream resulted in no significant changes in TEWL or Corneometer® readings throughout the study period. The SLS-containing aqueous cream resulted in a significant increase in TEWL from Day 0 to Days 3 and 7. All test moisturizer creams showed no significant changes in their clinical assessment scores. Conclusion: The results of our study indicate that SLS-free aqueous cream has a lower irritancy potential than SLS-containing aqueous cream, with the same level of maintenance of skin barrier integrity and hydration. SLS-free aqueous cream also appears to be less irritating to the skin than other non-SLS generic and commercial moisturizers tested.
Asunto(s)
Vesícula/patología , Histiocitosis de Células de Langerhans/patología , Piel/patología , Administración Cutánea , Antígenos CD/análisis , Biomarcadores/análisis , Biopsia , Vesícula/tratamiento farmacológico , Vesícula/inmunología , Fármacos Dermatológicos/administración & dosificación , Histiocitosis de Células de Langerhans/tratamiento farmacológico , Histiocitosis de Células de Langerhans/inmunología , Humanos , Inmunohistoquímica , Lactante , Lectinas Tipo C/análisis , Masculino , Lectinas de Unión a Manosa/análisis , Furoato de Mometasona/administración & dosificación , Inducción de Remisión , Piel/efectos de los fármacos , Piel/inmunología , Resultado del TratamientoRESUMEN
INTRODUCTION: Patient eczema severity time (PEST) is a new atopic dermatitis (AD) scoring system based on patients' own perception of their disease. Conventional scales such as SCORing of atopic dermatitis (SCORAD) reflect the clinician's observations during the clinic visit. Instead, the PEST score captures eczema severity, relapse and recovery as experienced by the patient or caregiver on a daily basis, promoting patient engagement, compliance with treatment and improved outcomes. This study aims to determine the correlation between carer-assessed PEST and clinician-assessed SCORAD in paediatric AD patients after 12 weeks of treatment using a ceramide-dominant therapeutic moisturizer. METHODS: Prospective, open-label, observational, multi-centre study in which children with AD aged 6 months to 6 years were treated with a ceramide dominant therapeutic moisturizer twice daily for 12 weeks; 58 children with mild-to-moderate AD were included. Correlation between the 7-day averaged PEST and SCORAD scores for assessment of AD severity was measured within a general linear model. PEST and SCORAD were compared in week 4 and week 12. RESULTS: At week 12, a moderate correlation was found between the SCORAD and PEST scores (r = 0.51). The mean change in SCORAD and PEST scores from baseline to week 12 was -11.46 [95% confidence interval (CI) -14.99 to -7.92, p < 0.0001] and -1.33 (95% CI -0.71 to -0.10, p < 0.0001) respectively. PEST demonstrated greater responsiveness to change (33.3% of scale) compared to SCORAD (13.8% of scale). CONCLUSION: The PEST score correlates well with the SCORAD score and may have improved sensitivity when detecting changes in the severity of AD. The ceramide-dominant therapeutic moisturizer used was safe and effective in the management of AD in young children. FUNDING: Hyphens Pharma Pte Ltd. TRIAL REGISTRATION: clinicaltrials.gov identifier, NCT02073591.
RESUMEN
Decorative tattooing has been linked with a range of complications, with pseudolymphoma being unusual and challenging to manage. We report a case of tattoo-induced pseudolymphoma, who failed treatment with potent topical and intralesional steroids. She responded well to sequential treatment with ablative fractional resurfacing (AFR) followed by Q-Switched (QS) Nd:YAG 532 nm laser. Interestingly, we managed to document the clearance of her tattoo pigments after laser treatments on histology and would like to highlight the use of special stains such as the Grocott's Methenamine Silver (GMS) stain as a useful method to assess the presence of tattoo pigment in cases where dense inflammatory infiltrates are present.
RESUMEN
Porokeratosis is a rare disorder of skin keratinisation characterised by a cornoid lamella. We reviewed its associations with immunosuppression and phototherapy, as well as the risks of malignant progression. This is a retrospective review on all cases of porokeratosis seen at the National Skin Centre, Singapore, between 2000 and 2010. A total of 94 patients were reviewed. Clinical and histological diagnoses were confirmed in 63% patients. Most patients were Chinese (89%) with a mean age of 51.6 years. The male to female ratio was 1.4:1. The four main clinical variants were classical porokeratosis of Mibelli (56%), disseminated superficial actinic porokeratosis (DSAP) (18%), disseminated superficial porokeratosis (DSP) (11%), and linear porokeratosis (13%). Phototherapy-induced porokeratosis, seen in three patients, is rare. Seven cases of porokeratosis occurred in patients who were immunosuppressed. Progression of porokeratosis to malignancy is uncommon and was observed in three patients. The most common treatments included cryotherapy (26.5%) as well as topical steroids or retinoids (38.1%). A good response, defined as clear or almost clear lesions, occurred in 16% patients. The most common presentation of porokeratosis in our review was a middle-aged male patient with an asymptomatic lesion of porokeratosis of Mibelli over the extremities. No particular immunosuppressive drug was implicated. Porokeratosis associated with ultraviolet phototherapy or malignancy is rare. Progression of porokeratosis to malignancy arose in the disseminated variants, with a possible correlation with age. This is the largest institutional retrospective review of porokeratosis to date and highlights the major epidemiological characteristics of this condition.